Description: 1988 Valuation Actuary Symposium, In this session, the presenter suggests the value of the Reg 126 testing is a function of the attitude of the company toward the process. He also explored the differences in results by product of using deterministic versus stochastic scenarios.

Description: This discussion at the 1989 Valuation Actuary Symposium by a Canadian regulatory panel covers reserves for AIDS, the impact of the proposed Policy Premium Method of reserving, and comments about the governmental examination process.

Description: This session at the 1989 Valuation Actuary Symposium looks at issues of the AIDS/HIV epidemic including the extra mortality, reserving options, a proposed actuarial standard of practice, and also covers the Canadian perspective.

Description: This session at the 1989 Valuation Actuary Symposium looks at issues created by changes in financial reporting in Canada related to the Policy Premium Method and dynamic solvency testing.

Description: This session from the 1993 Valuation Actuary Symposium looks at asset models and economic scenario generation.

Description: Valuation Actuary Symposium This is a session on cash flow testing issues in small companies.

Description: 1996 Valuation Actuary Symposium. This session about life and annuity valuation issues discussed Guideline 33, Guideline MMM, separate accont surplus, equity-indexed annuities, the annuity mortality regulation, the model illustration regulation, and XXX.

Description: This session at the 1998 Valuation Actuary Symposium looks at how companies can use the cash-flow testing structure for additional analysis and be more useful to the managment of the company. The concept of transfer pricing within a life company is explained.

Description: This is the table of contents.

Description: This paper presents a method involving re-sampling 'with replacement but without random numbers', numerical convolutions for sums and quotients, and estimation of confidence intervals for trend in average size claim. In this paper, this method is applied to major medical claims.